PARALLAX HEALTH SCIENCES, INC.·5

Mar 4, 6:35 PM ET

Gorlach Jorn 5

5 · PARALLAX HEALTH SCIENCES, INC. · Filed Mar 4, 2020

Insider Transaction Report

Form 5
Period: 2019-12-31
Gorlach Jorn
Director10% Owner
Transactions
  • Award

    WARRANTS

    2019-07-25+419,9986,299,306 total(indirect: By Hamburg Investment Co)
    Exercise: $0.10From: 2019-07-25Exp: 2024-07-25COMMON STOCK (419,998 underlying)
  • Award

    COMMON STOCK (RESTRICTED)

    2019-07-25+1,151,44320,229,557 total(indirect: By LLC)
  • Disposition to Issuer

    WARRANTS (PREFERRED SERIES B)

    2019-01-2315,0003,770,893 total(indirect: By Hamburg Investment Co)
    Exercise: $0.25From: 2017-01-23Exp: 2019-01-23COMMON STOCK (300,000 underlying)
  • Award

    COMMON STOCK (RESTRICTED)

    2019-07-25+229,36820,458,925 total(indirect: By Hamburg Investment Co)
  • Award

    WARRANTS

    2019-07-25+2,108,4155,879,308 total(indirect: By LLC)
    Exercise: $0.25From: 2019-07-25Exp: 2024-07-25COMMON STOCK (2,108,415 underlying)
Footnotes (2)
  • [F1]Expiration of warrants issued in connection with Series B Convertible Preferred Stock.
  • [F2]Issued pursuant to Settlement Agreement / Promissory Note exchange dated July 25, 2019.

Documents

1 file
  • 5
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT